Key result
Influenza A virus NEP drastically inhibited recombinant viral polymerase-mediated CAT expression in a dose-dependent manner, reducing vRNA, cRNA, and mRNA levels.
The influenza A virus NEP (NS2) protein downregulates virus-specific RNA synthesis, suggesting a regulatory role during the virus life cycle.
NEP-mediated downregulation of viral RNA synthesis may modulate influenza replication; leaves open its role in vivo and as an antiviral target.
The influenza A virus NEP (NS2) protein is an structural component of the viral particle. To investigate whether this protein has an effect on viral RNA synthesis, we examined the expression of an influenza A virus-like chloramphenicol acetyltransferase (CAT) RNA in cells synthesizing the four influenza A virus core proteins (nucleoprotein, PB1, PB2, and PA) and NEP from recombinant plasmids. Influenza A virus NEP inhibited drastically, and in a dose-dependent manner, the level of CAT expression mediated by the recombinant influenza A virus polymerase. This inhibitory effect was not observed in an analogous artificial system in which expression of a synthetic CAT RNA is mediated by the core proteins of an influenza B virus. This result ruled out the possibility that inhibition of reporter gene expression was due to a general toxic effect induced by NEP. Analysis of the virus-specific RNA species that accumulated in cells expressing the type A recombinant core proteins and NEP showed that there was an important reduction in the levels of minireplicon-derived vRNA, cRNA, and mRNA molecules. Taken together, the results obtained suggest a regulatory role for NEP during virus-specific RNA synthesis, and this finding is discussed regarding the biological implications for the virus life cycle.
No takes yet. Share an insight, caveat, or question.
Bullido et al. (2001) studied Influenza A virus infection (in vitro model). Influenza A virus NEP (NS2) protein vs. Analogous artificial system with influenza B virus core proteins was evaluated on Level of CAT expression and minireplicon-derived vRNA, cRNA, and mRNA molecules. Influenza A virus NEP drastically inhibited recombinant viral polymerase-mediated CAT expression in a dose-dependent manner, reducing vRNA, cRNA, and mRNA levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: